BRISTOL MYERS SQUIBB

bristol-myers-squibb-logo

Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products. The company operates in two segments, Pharmaceuticals, and Nutritionals. The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.

#SimilarOrganizations #People #Financial #Event #Website #More

BRISTOL MYERS SQUIBB

Social Links:

Industry:
Biotechnology Health Care Medical Pharmaceutical

Founded:
1887-01-01

Address:
New York, New York, United States

Country:
United States

Website Url:
http://www.bms.com

Total Employee:
10001+

Status:
Active

Contact:
(212)546-4000

Total Funding:
6.08 B USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Font Awesome Domain Not Resolving Global Site Tag Nginx


Similar Organizations

accendowave-logo

AccendoWave

AccendoWave provides discomfort detection, monitoring, and reporting devices for the reduction of human suffering.

amerisourcebergen-logo

AmerisourceBergen

AmerisourceBergen provides pharmaceutical supply chain distribution & pharmacy management solutions.

bartell-drugs-logo

Bartell Drugs

Bartell Drugs is the oldest family owned drugstore chain in the USA.

dohmen-life-science-service-logo

Dohmen Life Science Service

Intelligent outsourcing for drug and device manufacturers.

eli-lilly-logo

Eli Lilly

Eli Lilly engages in the discovery, development, manufacture, and sale of products in pharmaceutical products business segment.

g-d-searle-logo

G. D. Searle

G. D. Searle, LLC is a research-based pharmaceutical company that manufactures and markets prescription pharmaceuticals and other

gilead-science-korea-logo

Gilead Science Korea

Gilead Science Korea is engaged in medical, licensing, marketing, and sales activities.

gilead-sciences-logo

Gilead Sciences

Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.

johnson-johnson-logo

Johnson & Johnson

Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.

knmp-logo

KNMP

KNMP is the Royal Dutch Society for the Promotion of Pharmacy is the umbrella professional and branch organization of pharmacists.

laboratoires-genevrier-logo

Laboratoires Genevrier

Laboratoires Genevrier engages in improving human health by offering an extensive range of innovative and effective pharmaceutical products.

mayinglong-logo

Mayinglong

Mayinglong Pharmaceutical Group manufactures and markets pharmaceutical products.

medical-products-laboratories-logo

Medical Products Laboratories

Medical Products is into research, development, manufacturing and distribution of innovative products to our customers.

merck-logo

Merck

Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.

merck-logo

Merck

Merck is a pharmaceutical and chemical enterprise that develops prescription drugs and over-the-counter products.

ono-pharmaceutical-logo

ONO Pharmaceutical

ONO Pharmaceutical is focused on the production, purchase, and sale of pharmaceuticals and diagnostic reagents.

orajel-logo

Orajel

Orajel engages in the manufacture and marketing of cosmetics and over-the-counter pharmaceuticals.

pfizer-logo

Pfizer

Pfizer provides access to safe and effective and affordable medicines and health care services.

not_available_image

Pleasant Valley Fund

Pleasant Valley Fund LLC is an early and seed stage investment fund focused on mobile, data, health, biomedical and pharma verticals.

roxane-laboratories-logo

Roxane Laboratories

Roxane Laboratories engages in the research, development, manufacture, marketing, sale, and distribution of generic pharmaceuticals.

shionogi-logo

Shionogi

Shionogi supply the best possible medicine to protect the health and wellbeing of the patients they serve.

sustained-nano-systems-logo

Sustained Nano Systems

Sustained Nano Systems is a provider of nanoparticle-based drug delivery technology.

syndel-logo

Syndel

For more than 40 years, Syndel has been a leader in developing high quality aquaculture pharmaceutical health and nutritional products.

teva-pharmaceutical-industries-logo

Teva Pharmaceutical Industries

Teva Pharmaceutical Industries is a pharmaceutical company specializing in the development, production and marketing of generic.

university-of-california-san-francisco-logo

University of California, San Francisco

Director of the Lab for Advanced Cytometry (LAC) and the Sony Biotechnology Center at UCSF in the Department of Laboratory Medicine

walgreens-logo

Walgreens

Walgreens is a pharmacy, health, and wellness service center that offers trained infusion nurses and pharmacists to treat patients.

wepa-apothekenbedarf-gmbh-co-kg-logo

WEPA APOTHEKENBEDARF GmbH & Co KG

WEPA APOTHEKENBEDARF GmbH & Co KG distributes healthcare, laboratory, and formulation equipment and products for pharmacies.

yliopiston-apteekki-logo

Yliopiston Apteekki

Yliopiston Apteekki is an online store that offers a wide range of medicine, cosmetics, vitamins and nutritional supplements.


Current Advisors List

giovanni-caforio_image

Giovanni Caforio Chairman @ Bristol Myers Squibb
Board_member
2017-05-01

vicki-sato_image

Vicki Sato Member of the Board of Directors @ Bristol Myers Squibb
Board_member

lewis-campbell_image

Lewis Campbell Board of Directors @ Bristol Myers Squibb
Board_member

laurie-glimcher_image

Laurie Glimcher Board of Directors @ Bristol Myers Squibb
Board_member

gerald-storch_image

Gerald Storch Board of Directors @ Bristol Myers Squibb
Board_member

lamberto-andreotti_image

Lamberto Andreotti Chairman of the Board @ Bristol Myers Squibb
Board_member

thomas-lynch_image

Thomas Lynch Member of the Board of Directors @ Bristol Myers Squibb
Board_member

michael-grobstein_image

Michael Grobstein Board of Directors @ Bristol Myers Squibb
Board_member

Current Employees Featured

john-damonti_image

John damonti
John damonti Foundation President @ Bristol Myers Squibb
Foundation President
1991-09-01

sandra-leung_image

Sandra Leung
Sandra Leung Senior Vice President, General Counsel & Secretary @ Bristol Myers Squibb
Senior Vice President, General Counsel & Secretary
2007-02-01

chris-boerner_image

Chris Boerner
Chris Boerner Executive Vice President, Chief Commercialization Officer @ Bristol Myers Squibb
Executive Vice President, Chief Commercialization Officer
2018-07-01

mita-maity_image

Mita Maity
Mita Maity Research Scientist @ Bristol Myers Squibb
Research Scientist
2011-11-01

douglas-kou_image

Douglas Kou
Douglas Kou Co-Chair Observational Protocol Review Committee @ Bristol Myers Squibb
Co-Chair Observational Protocol Review Committee
2012-07-01

frรฉdรฉric-baribaud_image

Frรฉdรฉric Baribaud
Frรฉdรฉric Baribaud Academic Research Collaboration Lead @ Bristol Myers Squibb
Academic Research Collaboration Lead
2021-04-01

hommy-almonte_image

Hommy Almonte
Hommy Almonte Immuno-Oncology Field Sales Trainer @ Bristol Myers Squibb
Immuno-Oncology Field Sales Trainer
2019-01-01

doug-bassett_image

Doug Bassett
Doug Bassett SVP Informatics & Predictive Sciences @ Bristol Myers Squibb
SVP Informatics & Predictive Sciences
2019-11-01

debra-boyko-debrito_image

Debra Boyko-DeBrito
Debra Boyko-DeBrito Director Content Management Solutions @ Bristol Myers Squibb
Director Content Management Solutions
1986-09-01

jennifer-klesh_image

Jennifer Klesh
Jennifer Klesh Associate Director @ Bristol Myers Squibb
Associate Director
2018-11-01

Founder


john-ripley-myers_image

John Ripley Myers

william-mclaren-bristol_image

William McLaren Bristol

Stock Details


Company's stock symbol is NYSE:BMY

Acquisitions List

Date Company Article Price
2022-06-03 Turning Point Therapeutics Turning Point Therapeutics acquired by Bristol Myers Squibb 4.1 B USD
2020-10-05 MyoKardia MyoKardia acquired by Bristol Myers Squibb 13.1 B USD
2020-08-24 Forbius Forbius acquired by Bristol Myers Squibb N/A
2019-11-20 Celgene Celgene acquired by Bristol Myers Squibb N/A
2019-01-03 Celgene Celgene acquired by Bristol Myers Squibb 74 B USD
2017-08-03 IFM Therapeutics IFM Therapeutics acquired by Bristol Myers Squibb N/A
2016-07-05 Cormorant Pharmaceuticals Cormorant Pharmaceuticals acquired by Bristol Myers Squibb N/A
2016-03-23 Padlock Therapeutics Padlock Therapeutics acquired by Bristol Myers Squibb 600 M USD
2015-11-02 Cardioxyl Pharmaceuticals Cardioxyl Pharmaceuticals acquired by Bristol Myers Squibb 2 B USD
2015-02-23 Flexus Biosciences Flexus Biosciences acquired by Bristol Myers Squibb 1.25 B USD

Investors List

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Post-IPO Equity - Bristol Myers Squibb

osage-university-partners_image

OUP (Osage University Partners)

OUP (Osage University Partners) investment in Post-IPO Equity - Bristol Myers Squibb

aperture-venture-partners_image

Aperture Venture Partners

Aperture Venture Partners investment in Post-IPO Equity - Bristol Myers Squibb

greg-bailey_image

Greg Bailey

Greg Bailey investment in Post-IPO Equity - Bristol Myers Squibb

connecticut-innovations_image

Connecticut Innovations

Connecticut Innovations investment in Post-IPO Equity - Bristol Myers Squibb

knoll-capital-management_image

Knoll Capital Management

Knoll Capital Management investment in Post-IPO Equity - Bristol Myers Squibb

vivo-capital_image

Vivo Capital

Vivo Capital investment in Post-IPO Equity - Bristol Myers Squibb

venrock_image

Venrock

Venrock investment in Post-IPO Equity - Bristol Myers Squibb

litmore-capital_image

Litmore Capital

Litmore Capital investment in Post-IPO Equity - Bristol Myers Squibb

carl-icahn_image

Carl Icahn

Carl Icahn investment in Post-IPO Equity - Bristol Myers Squibb

Investments List

Date Company Article Money raised
2022-09-08 Autobahn Therapeutics Bristol Myers Squibb investment in Venture Round - Autobahn Therapeutics 32.7 M USD
2022-09-06 ArsenalBio Bristol Myers Squibb investment in Series B - ArsenalBio 220 M USD
2022-08-25 Aktis Oncology Bristol Myers Squibb investment in Series A - Aktis Oncology 84 M USD
2022-07-20 BigHat Biosciences Bristol Myers Squibb investment in Series B - BigHat Biosciences 75 M USD
2022-06-08 Owkin Bristol Myers Squibb investment in Series B - Owkin 50 M USD
2022-06-02 Transition Bio Bristol Myers Squibb investment in Series A - Transition Bio 50 M USD
2022-05-31 Sapience Therapeutics Bristol Myers Squibb investment in Series B - Sapience Therapeutics 41 M USD
2022-05-11 Nuvig Therapeutics Bristol Myers Squibb investment in Series A - Nuvig Therapeutics 47 M USD
2022-04-28 Octant Bio Bristol Myers Squibb investment in Series B - Octant Bio 80 M USD
2022-04-14 Be Biopharma Bristol Myers Squibb investment in Series B - Be Biopharma 130 M USD

Newest Events participated

smit-congress-2019_event_image Participated in SMIT CONGRESS 2019 on 2019-10-10 as exhibitor

clinical-biomarkers-world-cdx_event_image Participated in Clinical Biomarkers & World CDx on 2018-10-04 as sponsor

mixiii-biomed-2018_event_image Participated in Mixiii Biomed 2018 on 2018-05-15 as sponsor

nordic-life-science-days-2017_event_image Participated in Nordic life science Days 2017 on 2017-09-12 as sponsor

fast-company-innovation-festival_event_image Participated in Fast Company Innovation Festival on 2016-11-09 as sponsor

Official Site Inspections

http://www.bms.com Semrush global rank: 106.06 K Semrush visits lastest month: 919.04 K

  • Host name: 45.60.150.161
  • IP address: 45.60.150.161
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Bristol Myers Squibb"

Our leadership team - Bristol Myers Squibb

Meet the executive leaders at Bristol Myers Squibb who are not only responsible for day-to-day operations, but are also innovators in the biotech industry committed to patients, customers, employees, community and stockholders.See details»

Corporate governance and management - Bristol Myers Squibb

Find out about Bristol Myers Squibb's corporate governance, which ensures the company operates in the most reliable, efficient, transparent and ethical manner.See details»

Global Biopharmaceutical Company

Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.See details»

Our company: Industry leadership in BioPharma - Bristol Myers โ€ฆ

Learn more about Bristol Myers Squibb, a global biopharma company dedicated to discover, develop and deliver innovative medicines to patients with serious diseases.See details»

Bristol Myers Squibb - Wikipedia

The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, [2] BMS is one of the world's largest pharmaceutical โ€ฆSee details»

Login - myBMS

Secure login portal for Bristol Myers Squibb employees to access company resources.See details»

People and business resource groups - Bristol Myers Squibb

Read about our People and Business Resource Groups (PBRGs) at Bristol Myers Squibb that focus on sustaining a culture of diversity and inclusion to achieve our patient-focused mission โ€ฆSee details»

Bristol-Myers Squibb Org Chart + Executive Team

The org chart of Bristol-Myers Squibb contains its 180 main executives like Christopher Boerner, David Elkins and Greg Meyers.See details»

Bristol Myers-Squibb - Our mission and our โ€ฆ

To our patients and customers We commit to scientific excellence and investment in biopharmaceutical research and development to provide innovative, high-quality medicines that address the โ€ฆSee details»

2024 Impact Report - Bristol Myers Squibb

Explore Bristol Myers Squibb's 2024 Impact Report to discover our commitment to environmental, social and governance practices. Learn about our progress, initiatives and future โ€ฆSee details»

Bristol-Myers Squibb Announces Post-Closing Leadership Team

Jun 5, 2019 Samit Hirawat, M.D., will join Bristol-Myers Squibb as the Chief Medical Officer, Global Drug Development, leading the development organization across therapeutic areas. โ€ฆSee details»

BMS Careers

Discover what it means to have a meaningful career. At Bristol Myers Squibb, you'll transform patients' lives and help them prevail over serious diseases.See details»

Bristol Myers-Squibb - People - globalcitizens.bms.com

Making A Difference Behind everything we do is a human network of thousands of people around the world working tirelessly to help bring transformational medicines to patients facing serious โ€ฆSee details»

Bristol Myers Squibb - Global Health Progress

Learn more about BMS. The Bristol Myers Squibb Foundation The Bristol Myers Squibb Foundation, an independent charitable organization, focuses on communities most at risk of โ€ฆSee details»

Bristol Myers Squibb - 2019 Annual Report - PBRG

Bristol Myers Squibb Network of Women (B-NOW) Partnered with/sponsored professional development activities for BMS women in the U.S. and E.U. to help prepare them for โ€ฆSee details»

The power of inclusion - Bristol Myers Squibb

Learn more about BMSโ€™ commitment to diversity and inclusion and how our People, Business and Resource Groups (PBRGs) help inform key business decisions and enhance our global patient โ€ฆSee details»

Annual Report 2021 - Bristol Myers Squibb

At Bristol Myers Squibb, valuing diverse perspectives is deliberate, and strengthening a culture of inclusion is intentional. Our global People & Business Resource Groups (PBRGs) are aligned โ€ฆSee details»

Learn Why Two Science Leaders Who Left BMS Were Inspired to โ€ฆ

Dec 19, 2024 Delivering groundbreaking treatments and doing transformative work. Thatโ€™s what motivated two scientists who had worked for BMS to return after pursuing opportunities โ€ฆSee details»

Bristol Myers Squibb CEO calls for policy certainty in U.S. - STAT

6 days ago Bristol Myers Squibb CEO warns against โ€œslashing U.S. investment in medicines or importing lackluster policies of less innovative health care systems.โ€See details»

Bristol Myers Squibb - Bristol Myers Squibb Reports First Quarter ...

Apr 24, 2025 Financial Guidance Bristol Myers Squibb is raising key 2025 non-GAAP line-item guidance assumptions as outlined below. The company is increasing its full-year revenue โ€ฆSee details»

linkstock.net © 2022. All rights reserved